Loading...
Market
Will Dexcom Stelo receive a major endorsement from a national diabetes association by the end of 2024?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
Official announcements from national diabetes associations
Story
Dexcom Launches First OTC Glucose Monitor in U.S.
Aug 26, 2024, 10:06 AM
Dexcom has launched Stelo, the first over-the-counter continuous glucose monitor (CGM) in the United States. The device, announced earlier this year at CES 2024, aims to provide a more affordable option for people with Type 2 diabetes to access CGMs. The availability of Stelo marks a significant step in the fight against diabetes by improving accessibility to essential monitoring technology.
View original story
Similar markets
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Include Omnipod 5 as a recommended device • 25%
Include Omnipod 5 with restrictions • 25%
Do not include Omnipod 5 • 25%
No change in guidelines • 25%
Less than 3 stars • 25%
3 to 3.9 stars • 25%
4 to 4.4 stars • 25%
4.5 to 5 stars • 25%